Enterprise Value
9.409B
Cash
5.567M
Avg Qtr Burn
-3.218M
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
0.05%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sarconeos (BIO101) Details COVID-19 | NDA FDA meeting | |
Sarconeos (BIO101) Details Sarcopenia | Phase 3 Initiation | |
Sarconeos (BIO101) Details Duchenne muscular dystrophy | Phase 1/2 Initiation |